Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ANHYDRON

CYCLOTHIAZIDE

Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ANHYDRON is listed in Drugs@FDA under application 013157 (NDA).

Marketing status: Discontinued Active ingredient CYCLOTHIAZIDE Form and strength TABLET;ORAL - 2MG Sponsor LILLY Submission history Latest submission status date: 1990-11-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview ANHYDRON is listed in Drugs@FDA under application 013157 (NDA). Marketing status: Discontinued Active ingredient CYCLOTHIAZIDE Form and strength TABLET;ORAL - 2MG Sponsor LILLY Submission history Latest submission status date: 1990-11-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.